CN Stock MarketDetailed Quotes

000513 Livzon Pharmaceutical Group Inc.

Watchlist

36.20
-0.07-0.19%

Trading Jan 21 10:39 CST

32.99BMarket Cap16.29P/E (TTM)

Livzon Pharmaceutical Group Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Livzon Pharmaceutical Group Inc. Q4 2024 Estimates Date

Currency：HKDMar 27, 2025

	Estimate	YoY
Revenue	2.95B	-3.34%
EPS	0.43	+1.77%

Analyst Rating

Strong Buy

Jan 20, 2025

Livzon Pharmaceutical Group Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.524B	--
--	2024/Q4	-- / 2.774B	--
--	2024/Q3	2.799B / 3.252B	--
--	2024/Q2	3.040B / 3.207B	--
--	2024/Q1	3.243B / 3.357B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.524B--

--2024/Q4-- / 2.774B--

--2024/Q32.799B / 3.252B--

--2024/Q23.040B / 3.207B--

--2024/Q13.243B / 3.357B--

Unlock Free Earnings Estimates

Open Account

Livzon Pharmaceutical Group Inc. Earnings Reports

Livingstone Group: Report for the third quarter of 2024

Oct 23, 2024 12:00 ET

Livzon Pharmaceutical Group Inc.: Half-year report for the year 2024.

Aug 22, 2024 12:00 ET

Livzon Pharmaceutical Group Inc.: Summary of Half-Year Report in 2024.

Aug 22, 2024 12:00 ET

Livingstone Group: Report for the first quarter of 2024

Apr 23, 2024 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Anhui Bossco Environmental Protection Technology

300422

5.32 +20.09%

Fibocom Wireless Inc.

Shanghai Hajime Advanced Material Technology

301000

35.82 +13.75%

Hangzhou Kaierda Welding Robot

688255

40.34 +10.22%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 20, 2025

Strong Buy

Strong Buy
83.33%
Buy
16.67%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Monoclonal Antibody Concept